Dow Jones

38 686,32

1,51%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Blue Water Biotech Inc (BWV)
Blue Water Biotech Inc (BWV) Actualités

BWV

Blue Water Biotech (BWV)

Blue Water Biotech Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:BWV

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
21/12/2023	22h56	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BWV	Blue Water Biotech Inc
19/12/2023	13h00	GlobeNewswire Inc.	Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders	NASDAQ:BWV	Blue Water Biotech Inc
18/12/2023	13h00	GlobeNewswire Inc.	Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™	NASDAQ:BWV	Blue Water Biotech Inc
17/11/2023	23h23	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BWV	Blue Water Biotech Inc
02/11/2023	12h00	GlobeNewswire Inc.	Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company	NASDAQ:BWV	Blue Water Biotech Inc
01/11/2023	12h00	GlobeNewswire Inc.	Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)	NASDAQ:BWV	Blue Water Biotech Inc
30/10/2023	12h00	GlobeNewswire Inc.	Blue Water Biotech Issues Letter to Shareholders	NASDAQ:BWV	Blue Water Biotech Inc
10/10/2023	15h00	GlobeNewswire Inc.	Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO	NASDAQ:BWV	Blue Water Biotech Inc
28/08/2023	22h30	GlobeNewswire Inc.	Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q	NASDAQ:BWV	Blue Water Biotech Inc
15/08/2023	23h22	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:BWV	Blue Water Biotech Inc
10/08/2023	15h00	GlobeNewswire Inc.	Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water’s Commercial Products	NASDAQ:BWV	Blue Water Biotech Inc
03/08/2023	19h02	GlobeNewswire Inc.	Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds	NASDAQ:BWV	Blue Water Biotech Inc
01/08/2023	14h00	GlobeNewswire Inc.	Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds	NASDAQ:BWV	Blue Water Biotech Inc
31/07/2023	15h00	GlobeNewswire Inc.	Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians	NASDAQ:BWV	Blue Water Biotech Inc
25/07/2023	15h00	GlobeNewswire Inc.	Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®	NASDAQ:BWV	Blue Water Biotech Inc
17/07/2023	15h00	GlobeNewswire Inc.	Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities	NASDAQ:BWV	Blue Water Biotech Inc
11/07/2023	15h00	GlobeNewswire Inc.	Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support	NASDAQ:BWV	Blue Water Biotech Inc
06/07/2023	23h05	GlobeNewswire Inc.	Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products	NASDAQ:BWV	Blue Water Biotech Inc
06/07/2023	13h30	GlobeNewswire Inc.	Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio	NASDAQ:BWV	Blue Water Biotech Inc
29/06/2023	16h35	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:BWV	Blue Water Biotech Inc
28/06/2023	14h01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BWV	Blue Water Biotech Inc
28/06/2023	13h55	GlobeNewswire Inc.	Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform	NASDAQ:BWV	Blue Water Biotech Inc
21/06/2023	13h30	GlobeNewswire Inc.	Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio	NASDAQ:BWV	Blue Water Biotech Inc
14/06/2023	13h30	GlobeNewswire Inc.	Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment Areas	NASDAQ:BWV	Blue Water Biotech Inc
13/05/2023	00h32	GlobeNewswire Inc.	Blue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:BWV	Blue Water Biotech Inc
10/05/2023	18h15	GlobeNewswire Inc.	Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY	NASDAQ:BWV	Blue Water Biotech Inc
05/05/2023	12h08	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BWV	Blue Water Biotech Inc
28/04/2023	23h17	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:BWV	Blue Water Biotech Inc
26/04/2023	23h23	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BWV	Blue Water Biotech Inc
26/04/2023	21h44	GlobeNewswire Inc.	Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer	NASDAQ:BWV	Blue Water Biotech Inc